tirzepatide and type 2 diabetes once weekly for the treatment of obesity in people with (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide monotherapy in Chinese patients
Pay in 4 interest-free payments of $5.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23































